James Paul Lang - Dec 30, 2021 Form 4 Insider Report for OptimizeRx Corp (OPRX)

Role
Director
Signature
/s/ Doug Baker, POA for James Lang
Stock symbol
OPRX
Transactions as of
Dec 30, 2021
Transactions value $
$0
Form type
4
Date filed
1/3/2022, 03:45 PM
Previous filing
Oct 1, 2021
Next filing
Apr 1, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPRX Restricted Stock Units Award $0 +409 +122.46% $0.00 743 Dec 30, 2021 Common Stock 409 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F2 Grant to the Reporting Person of restricted stock units under the OptimizeRx Corp. 2021 Equity Incentive Plan. The restricted stock units granted vest on December 30, 2022, subject to continued service to the issuer through the vesting date. This restricted stock units granted are subject to accelerated vesting in the event that the recipient is subject to a qualified termination within a specified period of time prior to or following the closing of a change in control transaction.
F3 Not applicable.